A Study to Evaluate Systemic Amyloidosis Screening Through Ligament Biopsy at Time of Spinal Stenosis Surgery

Overview

About this study

The purpose of this study is to evaluate the prevalence of amyloidosis in patients undergoing surgical intervention for non-congenital spinal stenosis and spondyloarthropathy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age ≥ 45 years.
Undergoing surgical intervention for non-congenital spinal stenosis and/or spondyloarthropathy.
Able to consent.

Exclusion Criteria:

History of congenital spinal stenosis or congenital spondyloarthropathy.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Julie Rosenthal, M.D.	Closed for enrollment	Contact information: Denise White (480) 342-6741 White.Denise@mayo.edu

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Julie Rosenthal, M.D.

Closed for enrollment

Contact information:

Denise White

(480) 342-6741

White.Denise@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials